TTUHSC School of Pharmacy
HomeSOPFaculty & Staff Directory

Faculty & Staff Details

Profile for Sanjay Srivastava, PhD

Sanjay Srivastava

Sanjay Srivastava, PhD

  • Associate Academic Dean
  • Professor
Office Phone: 806-414-9211
Mail Address: 1406 S Coulter St
Amarillo TX 79106-1786


Dr. Sanjay K. Srivastava is a Professor of Biomedical Sciences specializing in Cancer Biology, Chemoprevention and Therapeutics. Prior to his arrival at TTUHSC, Dr. Srivastava served as an Assistant Professor in the Department of Pharmacology, University of Pittsburgh School of Medicine from 2000-2007 and was a full member of the University of Pittsburgh Cancer Institute. He did his post-doc from the University of Texas Medical Branch at Galveston, Texas from 1992-1995. Dr. Srivastava’s research is focused on melanoma, pancreatic, ovarian and breast cancer and is funded by grants from the National Cancer Institute, NIH. He has authored more than 100 research papers and is the Editor of three books. Dr. Srivastava is in the editorial board of several journals and is the member of societies including American Association for Cancer Research, Society of Toxicology and AAPS. He also serves in the grant review panels of National Institute of Health (NIH), Department of Defense and Susan G. Komen Breast Cancer Foundation. His research work has been featured by news agencies including BBC, MSNBC, CBS, ABC, Science News etc.

Selected Publications:

  • Jung JH, Yun M, Choo EJ, Kim SH, Jeong MS, Jung DB, Lee H, Kim EO, Kato N, Kim B, Srivastava SK, Kaihatsu K, Kim SH. A derivative of epigallocatechin-3-gallate induces apoptosis via SHP-1-mediated suppression of BCR-ABL and STAT3 signalling in chronic myelogenous leukaemia.. British journal of pharmacology 2015;172(14):3565-78.
  • Pramanik KC, Fofaria NM, Gupta P, Ranjan A, Kim SH, Srivastava SK. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.. Oncotarget 2015;6(13):11561-74.
  • Kim B, Srivastava SK, Kim SH. Caspase-9 as a therapeutic target for treating cancer.. Expert opinion on therapeutic targets 2015;19(1):113-27.
  • Fofaria NM, Ranjan A, Kim SH, Srivastava SK. Mechanisms of the Anticancer Effects of Isothiocyanates.. The Enzymes 2015;37:111-37.
  • Fofaria NM, Srivastava SK. STAT3 induces anoikis resistance, promotes cell invasion and metastatic potential in pancreatic cancer cells.. Carcinogenesis 2015;36(1):142-50.